Intentar ORO - Gratis

Bio Spectrum - March 2019

Vuélvete ilimitado con Magzter GOLD

Leer Bio Spectrum junto con más de 9000 revistas y periódicos con una sola suscripción

Ver catálogo

1 mes

$14.99

1 año $149.99

$149.99

$12/month

(OR)

Suscríbete sólo a Bio Spectrum

Regalo Bio Spectrum

Cancelar en cualquier momento.

(Sin compromisos) ⓘ

Si no estás satisfecho con tu suscripción, puedes enviarnos un correo electrónico a help@magzter.com dentro de los 7 días posteriores a la fecha de inicio de la suscripción para recibir un reembolso completo. ¡Sin preguntas, lo prometemos! (Nota: No se aplica a compras de números individuales)

Suscripción digital

Acceso instantáneo ⓘ

Suscríbete ahora para comenzar a leer instantáneamente en el sitio web de Magzter, iOS, Android y las aplicaciones de Amazon.

Verificado seguro

pago ⓘ

Magzter es un comerciante verificado de Authorize.Net. Más información

En este número

Women Entrepreneurs: Tough Gets Going

During the recent budget announcement, interim finance minister Piyush Goyal announced that India has become the second-largest hub of startups globally. Although it is a matter of pride, a gender imbalance scenario here takes away the joy. India currently houses around 39000 startups but less than 10 per cent of these have founders as women. Reports over time have revealed that there is gender inequality within the areas of science, technology, engineering, and medicine (STEM). While women have been entering STEM fields in increasing numbers, there still remain large disparities in specific sub-fields. Against all odds, many women have started their own ventures in the field of life sciences and related healthcare sectors. BioSpectrum has compiled profiles of 26 such achievers who have successfully developed startups in the above mentioned fields in the past 6 years.

Bio Spectrum Description:

Editor: MM-Activ-Sci-Tech-Communication

Categoría: Business

Idioma: English

Frecuencia: Monthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.